Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joanne Hilden

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hord J, Shah M, Badawy SM, Matthews D, Hilden J, Wayne AS, Salsberg E, Leavey PS. The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1-Current state of the workforce. Pediatr Blood Cancer. 2017 Oct 25. PMID: 29068564.
      View in: PubMed
    2. Leavey PJ, Hilden JM, Matthews D, Dandoy C, Badawy SM, Shah M, Wayne AS, Hord J. The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2-Implications for fellowship training. Pediatr Blood Cancer. 2017 Oct 25. PMID: 29068565.
      View in: PubMed
    3. Dittmar M, Smith N, Warren B, Clark B, Wathen B, Hammett K, Reiter P, Hilden J, Goldenberg N, Branchford B. Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements. Thromb Res. 2017 06; 154:93-95. PMID: 28456027.
      View in: PubMed
    4. Badawy SM, Black V, Meier ER, Myers KC, Pinkney K, Hastings C, Hilden JM, Zweidler-McKay P, Stork LC, Johnson TS, Vaiselbuh SR. Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program. Pediatr Blood Cancer. 2017 Mar; 64(3). PMID: 27616578.
      View in: PubMed
    5. Rogers AE, Eisenman KM, Dolan SA, Belderson KM, Zauche JR, Tong S, Gralla J, Hilden JM, Wang M, Maloney KW, Dominguez SR. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report. Pediatr Blood Cancer. 2017 Mar; 64(3). PMID: 27616655.
      View in: PubMed
    6. Zweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatr Blood Cancer. 2016 Oct; 63(10):1723-30. PMID: 27295503.
      View in: PubMed
    7. Hilden J. It is Time to Let in Pediatric Palliative Care. Pediatr Blood Cancer. 2016 Apr; 63(4):583-4. PMID: 26797913.
      View in: PubMed
    8. Dantes R, Epson EE, Dominguez SR, Dolan S, Wang F, Hurst A, Parker SK, Johnston H, West K, Anderson L, Rasheed JK, Moulton-Meissner H, Noble-Wang J, Limbago B, Dowell E, Hilden JM, Guh A, Pollack LA, Gould CV. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting. Am J Infect Control. 2016 Feb; 44(2):138-45. PMID: 26601705.
      View in: PubMed
    9. Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, Ingles SA, Dunkel IJ, Hilden J, Packer RJ, Pollack IF, Gajjar A, Finlay JL. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group. Pediatr Neurol. 2015 Jul; 53(1):31-46. PMID: 26092413.
      View in: PubMed
    10. Salstrom JL, Coughlin RL, Pool K, Bojan M, Mediavilla C, Schwent W, Rannie M, Law D, Finnerty M, Hilden J. Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs. Pediatr Blood Cancer. 2015 May; 62(5):807-15. PMID: 25663663; PMCID: PMC4413050.
    11. Salzer WL, Jones TL, Devidas M, Dreyer ZE, Gore L, Winick NJ, Sung L, Raetz E, Loh ML, Wang CY, De Lorenzo P, Valsecchi MG, Pieters R, Carroll WL, Hunger SP, Hilden JM, Brown P. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Mar; 62(3):414-8. PMID: 25407157; PMCID: PMC4480675.
    12. Dreyer ZE, Hilden JM, Jones TL, Devidas M, Winick NJ, Willman CL, Harvey RC, Chen IM, Behm FG, Pullen J, Wood BL, Carroll AJ, Heerema NA, Felix CA, Robinson B, Reaman GH, Salzer WL, Hunger SP, Carroll WL, Camitta BM. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3). Pediatr Blood Cancer. 2015 Mar; 62(3):419-26. PMID: 25399948.
      View in: PubMed
    13. Acker SN, Linton J, Tan GM, Garrington TP, Bruny J, Hilden JM, Hoffman LM, Partrick DA. A multidisciplinary approach to the management of anterior mediastinal masses in children. J Pediatr Surg. 2015 May; 50(5):875-8. PMID: 25783332.
      View in: PubMed
    14. Dominguez SR, Dolan SA, West K, Dantes RB, Epson E, Friedman D, Littlehorn CA, Arms LE, Walton K, Servetar E, Frank DN, Kotter CV, Dowell E, Gould CV, Hilden JM, Todd JK. High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients. Clin Infect Dis. 2014 Aug 01; 59(3):401-3. PMID: 24785235.
      View in: PubMed
    15. Valentine MC, Linabery AM, Chasnoff S, Hughes AE, Mallaney C, Sanchez N, Giacalone J, Heerema NA, Hilden JM, Spector LG, Ross JA, Druley TE. Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report. Leukemia. 2014 Jun; 28(6):1235-41. PMID: 24301523; PMCID: PMC4045651.
    16. Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, Cao K, Cory L, Moore JS, Bantly AD, Yu QC, Chen IM, Atlas SR, Willman CL, Kundu M, Carroll AJ, Heerema NA, Devidas M, Hilden JM, Dreyer ZE, Hunger SP, Reaman GH, Felix CA. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood. 2013 Apr 04; 121(14):2689-703. PMID: 23393050; PMCID: PMC3617634.
    17. Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. J Clin Oncol. 2012 Jul 20; 30(21):2648-53. PMID: 22665539; PMCID: PMC4559602.
    18. Salzer WL, Jones TL, Devidas M, Hilden JM, Winick N, Hunger S, Carroll WL, Camitta B, Dreyer ZE. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. Pediatr Blood Cancer. 2012 Nov; 59(5):834-9. PMID: 22488662; PMCID: PMC4008315.
    19. Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, Hilden JM, Heerema NA, Radloff GA, Tower RL, Davies SM. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer. 2013 Jan; 60(1):31-4. PMID: 22422485; PMCID: PMC3381932.
    20. Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012 Apr 20; 30(12):1358-63. PMID: 22393086.
      View in: PubMed
    21. Sorrell AD, Alonzo TA, Hilden JM, Gerbing RB, Loew TW, Hathaway L, Barnard D, Taub JW, Ravindranath Y, Smith FO, Arceci RJ, Woods WG, Gamis AS. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group. Cancer. 2012 Oct 01; 118(19):4806-14. PMID: 22392565; PMCID: PMC3879144.
    22. Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, Felix CA, Reaman GH, Camitta B, Winick N, Carroll WL, Dreyer ZE, Hunger SP, Willman CL. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012 Feb 23; 119(8):1872-81. PMID: 22210879; PMCID: PMC3293641.
    23. Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, Loew TW, Arceci RJ, Barnard D, Doyle J, Massey G, Perentesis J, Ravindranath Y, Taub J, Smith FO. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood. 2011 Dec 22; 118(26):6752-9; quiz 6996. PMID: 21849481; PMCID: PMC3245202.
    24. Sam TN, Kersey JH, Linabery AM, Johnson KJ, Heerema NA, Hilden JM, Davies SM, Reaman GH, Ross JA. MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study. Pediatr Blood Cancer. 2012 Jun; 58(6):836-9. PMID: 21800415; PMCID: PMC3208122.
    25. Slater ME, Linabery AM, Spector LG, Johnson KJ, Hilden JM, Heerema NA, Robison LL, Ross JA. Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children's Oncology Group. Cancer Causes Control. 2011 Aug; 22(8):1197-204. PMID: 21691732; PMCID: PMC4836386.
    26. Frugé E, Lakoski JM, Luban N, Lipton JM, Poplack DG, Hagey A, Felgenhauer J, Hilden J, Margolin J, Vaiselbuh SR, Sakamoto KM. Increasing diversity in pediatric hematology/oncology. Pediatr Blood Cancer. 2011 Jul 15; 57(1):147-52. PMID: 21284078; PMCID: PMC3092025.
    27. Dussel V, Bona K, Heath JA, Hilden JM, Weeks JC, Wolfe J. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol. 2011 Mar 10; 29(8):1007-13. PMID: 21205758; PMCID: PMC4979235.
    28. Dreyer ZE, Dinndorf PA, Camitta B, Sather H, La MK, Devidas M, Hilden JM, Heerema NA, Sanders JE, McGlennen R, Willman CL, Carroll AJ, Behm F, Smith FO, Woods WG, Godder K, Reaman GH. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group. J Clin Oncol. 2011 Jan 10; 29(2):214-22. PMID: 21135279; PMCID: PMC3058277.
    29. Linabery AM, Puumala SE, Hilden JM, Davies SM, Heerema NA, Roesler MA, Ross JA. Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group. Br J Cancer. 2010 Nov 23; 103(11):1724-8. PMID: 20978510; PMCID: PMC2994226.
    30. Ullrich CK, Dussel V, Hilden JM, Sheaffer JW, Moore CL, Berde CB, Wolfe J. Fatigue in children with cancer at the end of life. J Pain Symptom Manage. 2010 Oct; 40(4):483-94. PMID: 20678889.
      View in: PubMed
    31. Johnson KJ, Roesler MA, Linabery AM, Hilden JM, Davies SM, Ross JA. Infant leukemia and congenital abnormalities: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Jul 15; 55(1):95-9. PMID: 20486175; PMCID: PMC2904947.
    32. Ullrich CK, Dussel V, Hilden JM, Sheaffer JW, Lehmann L, Wolfe J. End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood. 2010 May 13; 115(19):3879-85. PMID: 20228275.
      View in: PubMed
    33. Dussel V, Joffe S, Hilden JM, Watterson-Schaeffer J, Weeks JC, Wolfe J. Considerations about hastening death among parents of children who die of cancer. Arch Pediatr Adolesc Med. 2010 Mar; 164(3):231-7. PMID: 20194255; PMCID: PMC4760349.
    34. Bhat R, Malinge S, Gamis AS, Sorrell AD, Hilden JM, Ketterling RP, Paietta E, Tallman MS, Crispino JD. Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia. Leukemia. 2009 Nov; 23(11):2159-60. PMID: 19657363.
      View in: PubMed
    35. Salzer W, Dinndorf P, Dreyer Z, Hilden J, Reaman GH. Analysis of infectious complications in infants with acute lymphoblastic leukemia treated on the Children's Cancer Group Protocol 1953: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2009 Jun; 31(6):398-405. PMID: 19648788.
      View in: PubMed
    36. Jespersen CM, Kolmos HJ, Frydendall N, Hilden J, Gluud C, Hansen JF. Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial. J Antimicrob Chemother. 2009 Aug; 64(2):411-5. PMID: 19477891.
      View in: PubMed
    37. Mack JW, Joffe S, Hilden JM, Watterson J, Moore C, Weeks JC, Wolfe J. Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol. 2008 Oct 10; 26(29):4759-64. PMID: 18779605; PMCID: PMC2653133.
    38. Dussel V, Kreicbergs U, Hilden JM, Watterson J, Moore C, Turner BG, Weeks JC, Wolfe J. Looking beyond where children die: determinants and effects of planning a child's location of death. J Pain Symptom Manage. 2009 Jan; 37(1):33-43. PMID: 18538973; PMCID: PMC2638984.
    39. Zweidler-McKay PA, Hilden JM. The ABCs of infant leukemia. Curr Probl Pediatr Adolesc Health Care. 2008 Mar; 38(3):78-94. PMID: 18279790.
      View in: PubMed
    40. Norton A, Fisher C, Liu H, Wen Q, Mundschau G, Fuster JL, Hasle H, Zeller B, Webb DK, O'Marcaigh A, Sorrell A, Hilden J, Gamis A, Crispino JD, Vyas P. Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. Blood. 2007 Aug 01; 110(3):1077-9. PMID: 17644747.
      View in: PubMed
    41. Heald B, Hilden JM, Zbuk K, Norton A, Vyas P, Theil KS, Eng C. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome. Nat Clin Pract Oncol. 2007 Jul; 4(7):433-8. PMID: 17597708.
      View in: PubMed
    42. Spector LG, Davies SM, Robison LL, Hilden JM, Roesler M, Ross JA. Birth characteristics, maternal reproductive history, and the risk of infant leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):128-34. PMID: 17220341.
      View in: PubMed
    43. Johnston DL, Nagel K, O'Halloran C, Sencer SF, Kelly KM, Friebert S, Hilden JM, Friedman DL. Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2006 Dec; 47(7):955-8. PMID: 16411194.
      View in: PubMed
    44. Duncan J, Joselow M, Hilden JM. Program interventions for children at the end of life and their siblings. Child Adolesc Psychiatr Clin N Am. 2006 Jul; 15(3):739-58. PMID: 16797447.
      View in: PubMed
    45. Hutton N, Jones B, Hilden JM. From cure to palliation: managing the transition. Child Adolesc Psychiatr Clin N Am. 2006 Jul; 15(3):575-84, vii. PMID: 16797439.
      View in: PubMed
    46. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG, Salzer WL, Johnstone HS, Dreyer Z, Reaman GH. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006 Jul 15; 108(2):441-51. PMID: 16556894; PMCID: PMC1895499.
    47. Mack JW, Hilden JM, Watterson J, Moore C, Turner B, Grier HE, Weeks JC, Wolfe J. Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol. 2005 Dec 20; 23(36):9155-61. PMID: 16172457.
      View in: PubMed
    48. Friedman DL, Hilden JM, Powaski K. Issues and challenges in palliative care for children with cancer. Curr Pain Headache Rep. 2005 Aug; 9(4):249-55. PMID: 16004840.
      View in: PubMed
    49. Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):651-5. PMID: 15767345.
      View in: PubMed
    50. Friedman DL, Hilden JM, Powaski K. Issues and challenges in palliative care for children with cancer. Curr Oncol Rep. 2004 Nov; 6(6):431-7. PMID: 15485611.
      View in: PubMed
    51. Walter AW, Hilden JM. Brain tumors in children. Curr Oncol Rep. 2004 Nov; 6(6):438-44. PMID: 15485612.
      View in: PubMed
    52. Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol. 2004 Jul 15; 22(14):2877-84. PMID: 15254056.
      View in: PubMed
    53. Himelstein BP, Hilden JM, Boldt AM, Weissman D. Pediatric palliative care. N Engl J Med. 2004 Apr 22; 350(17):1752-62. PMID: 15103002.
      View in: PubMed
    54. Nielsen OW, Hilden J, McDonagh T, Fischer Hansen J. Survival differences between heart failure in general practices and in hospitals. Heart. 2003 Nov; 89(11):1298-302. PMID: 14594883; PMCID: PMC1767949.
    55. Hilden JM, Watterson J, Chrastek J. Tell the children. J Clin Oncol. 2003 May 01; 21(9 Suppl):37s-39s. PMID: 12743187.
      View in: PubMed
    56. Wolfe J, Friebert S, Hilden J. Caring for children with advanced cancer integrating palliative care. Pediatr Clin North Am. 2002 Oct; 49(5):1043-62. PMID: 12430625.
      View in: PubMed
    57. Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol. 2002 Jun-Jul; 24(5):337-42. PMID: 12142780.
      View in: PubMed
    58. Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ, Ettinger AG, Ettinger LJ, Franklin J, Gaynon PS, Hilden JM, Lange B, Majlessipour F, Mathew P, Needle M, Neglia J, Reaman G, Holcenberg JS, Stork L. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002 Mar 15; 99(6):1986-94. PMID: 11877270.
      View in: PubMed
    59. Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002 Jan; 24(1):2-5. PMID: 11902733.
      View in: PubMed
    60. Hilden JM, Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ. Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol. 2001 Jan 01; 19(1):205-12. PMID: 11134214.
      View in: PubMed
    61. Hilden JM, Watterson J, Chrastek J. Tell the children. J Clin Oncol. 2000 Sep; 18(17):3193-5. PMID: 10963650.
      View in: PubMed
    62. Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J, Cornelius A, Needle M, Heilman D, Boaz JC, Luerssen TG. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. J Neurosurg. 2000 Feb; 92(2):255-60. PMID: 10659012.
      View in: PubMed
    63. Balle J, Olofsson MJ, Hilden J. [Cannabis and pregnancy]. Ugeskr Laeger. 1999 Sep 06; 161(36):5024-8. PMID: 10489797.
      View in: PubMed
    64. Mantadakis E, Shannon KM, Singer DA, Finklestein J, Chan KW, Hilden JM, Sandler ES. Transient monosomy 7: a case series in children and review of the literature. Cancer. 1999 Jun 15; 85(12):2655-61. PMID: 10375115.
      View in: PubMed
    65. Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME, Reaman GH. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group. Leukemia. 1999 May; 13(5):679-86. PMID: 10374870.
      View in: PubMed
    66. Hilden JM, Watterson J, Longee DC, Moertel CL, Dunn ME, Kurtzberg J, Scheithauer BW. Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature. J Neurooncol. 1998 Dec; 40(3):265-75. PMID: 10066100.
      View in: PubMed
    67. Glasziou PP, Cole BF, Gelber RD, Hilden J, Simes RJ. Quality adjusted survival analysis with repeated quality of life measures. Stat Med. 1998 Jun 15; 17(11):1215-29. PMID: 9670411.
      View in: PubMed
    68. Ventegodt S, Hilden J, Zachau-Christiansen B. [Phenemal to pregnant women and children's intelligence and quality of life 31-33 years later]. Ugeskr Laeger. 1997 Jun 09; 159(24):3799-800. PMID: 9214060.
      View in: PubMed
    69. Hilden JM, Smith FO, Frestedt JL, McGlennen R, Howells WB, Sorensen PH, Arthur DC, Woods WG, Buckley J, Bernstein ID, Kersey JH. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Blood. 1997 May 15; 89(10):3801-5. PMID: 9160687.
      View in: PubMed
    70. Hilden JM, Frestedt JL, Kersey JH. Molecular analysis of infant acute leukemia. Leuk Lymphoma. 1997 Apr; 25(3-4):191-9. PMID: 9168430.
      View in: PubMed
    71. Matloub YH, Smith C, Bostrom B, Koerper MA, O'Leary M, Khuder S, Smithson WA, Nickerson HJ, Silberman T, Hilden J, Moertel CL, Month S, Monteleone P, Ramsay NK. One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children. J Pediatr Hematol Oncol. 1997 Mar-Apr; 19(2):110-4. PMID: 9149739.
      View in: PubMed
    72. Frestedt JL, Hilden JM, Kersey JH. AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31. DNA Cell Biol. 1996 Aug; 15(8):669-78. PMID: 8769569.
      View in: PubMed
    73. Gross TG, Hilden JM, Manivel JC, Ramsay NK, MacMahon EM. Concurrent Epstein-Barr virus associated non-Hodgkin lymphoma and recurrent Hodgkin disease. J Pediatr Hematol Oncol. 1996 May; 18(2):182-6. PMID: 8846135.
      View in: PubMed
    74. Hilden JM, Watterson J, Garr CL. Genetic testing for familial cancer. A clinician's perspective. Minn Med. 1996 Apr; 79(4):29-32. PMID: 8637487.
      View in: PubMed
    75. Smith FO, Rauch C, Williams DE, March CJ, Arthur D, Hilden J, Lampkin BC, Buckley JD, Buckley CV, Woods WG, Dinndorf PA, Sorensen P, Kersey J, Hammond D, Bernstein ID. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood. 1996 Feb 01; 87(3):1123-33. PMID: 8562938.
      View in: PubMed
    76. Frestedt JL, Hilden JM, Moore RO, Kersey JH. Differential expression of AF4/FEL mRNA in human tissues. Genet Anal. 1996 Jan; 12(3-4):147-9. PMID: 8673740.
      View in: PubMed
    77. Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23). Blood. 1995 Nov 15; 86(10):3876-82. PMID: 7579356.
      View in: PubMed
    78. Hilden JM, Kersey JH. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies. Leuk Lymphoma. 1994 Jul; 14(3-4):189-95. PMID: 7950907.
      View in: PubMed
    79. Hilden JM, Chen CS, Moore R, Frestedt J, Kersey JH. Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia. Cancer Res. 1993 Sep 01; 53(17):3853-6. PMID: 8358709.
      View in: PubMed
    80. Chen CS, Hilden JM, Frestedt J, Domer PH, Moore R, Korsmeyer SJ, Kersey JH. The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia. Blood. 1993 Aug 15; 82(4):1080-5. PMID: 8353274.
      View in: PubMed
    81. Hilden J, Glasziou PP, Habbema JD. A pitfall in utility assessment--patients' undisclosed investment decisions. Med Decis Making. 1992 Jan-Mar; 12(1):39-43. PMID: 1538631.
      View in: PubMed
    82. Holst K, Hilden J, Henningsen I. The unborn and newborn child. I. Risk factors predicting complicated delivery in a general population of 4,102 women. Acta Obstet Gynecol Scand. 1989; 68(8):699-706. PMID: 2631541.
      View in: PubMed
    83. Holst K, Henningsen I, Hilden J. The unborn and newborn child. II. Risk factors predicting perinatal morbidity and mortality in 4,138 infants. Acta Obstet Gynecol Scand. 1989; 68(8):707-12. PMID: 2631542.
      View in: PubMed
    84. Bell J, Hilden J, Bowling F, Pearn J, Brownlea A, Martin N. The impact of prenatal diagnosis on the occurrence of chromosome abnormalities. Prenat Diagn. 1986 Jan-Feb; 6(1):1-11. PMID: 2937036.
      View in: PubMed
    85. Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang. 1985; 48(2):89-104. PMID: 2416122.
      View in: PubMed
    86. Biering-Sørensen F, Hilden J, Biering-Sørensen K. Breast-feeding in Copenhagen, 1938-1977. Data on more than 365,000 infants. Dan Med Bull. 1980 Feb; 27(1):42-8. PMID: 7398379.
      View in: PubMed
    87. Jørgensen T, Biering-Sørensen F, Hilden J. Sudden infant death in Copenhagen 1956--1971. III. Perinatal and perimortal factors. Acta Paediatr Scand. 1979 Jan; 68(1):11-22. PMID: 758724.
      View in: PubMed
    88. Biering-Sørensen F, Jørgensen T, Hilden J. Sudden infant death in Copenhagen 1956--1971. II. Social factors and morbidity. Acta Paediatr Scand. 1979 Jan; 68(1):1-9. PMID: 758723.
      View in: PubMed
    89. Hilden J, Ronnike F. On birth weight and gestation period in infants born to mothers with Addison's disease. Dan Med Bull. 1971 Jun; 18(3):62-5. PMID: 5566384.
      View in: PubMed
    Hilden's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)